Landscape

Law Firm Turns Opioid Case Fees Into Securities for Investors, Shifting Legal Landscape

by

In a bold move that blurs the lines between legal practice and financial innovation, a New York-based law firm is transforming its future legal fees from opioid litigation into securities for investment. Napoli Shkolnik PLLC, a prominent player in mass tort litigation, has packaged its anticipated earnings from approximately $1.3 billion in settlements with opioid manufacturers and pharmacies—including giants like McKesson, Janssen, CVS, and Walgreens—into a new financial product. These settlements, detailed in a Securities and Exchange Commission filing, mark the company’s strategy to monetize anticipated profits upfront. This approach reflects a growing trend where … Read more

Sebi’s New Pitch: Allowing Part-Time Professionals to Become Investment Advisors Could Reshape the Financial Advice Landscape

by

Mumbai, India — In an education landscape often limited to conventional academic pursuits, individuals like M. Pattabiraman, a physics professor at IIT Madras, are breaking molds. Renowned for his financial acumen, Pattabiraman has developed financial calculators so valuable they’ve been featured on the Securities and Exchange Board of India’s (Sebi) investor education site. Similarly, Vijay Malik, formerly a practicing doctor, carved out a new path as a successful equity research analyst and now manages a popular finance blog. This shift signifies a broader trend of professionals diversifying into financial advising, despite regulatory constraints. Currently, Sebi’s … Read more

Supreme Court’s Latest Ruling on Purdue Case Redefines Legal Landscape for Mass Torts Defendants

by

Washington — In a landmark decision, the U.S. Supreme Court has issued a ruling that significantly affects the strategy of mass tort defendants, notably altering their range of options in legal proceedings. This pivotal ruling, centering on Purdue Pharma’s high-profile bankruptcy case, has implications for how large-scale legal actions against corporations may be structured in the future. The case arose from Purdue Pharma’s attempt to settle thousands of lawsuits tied to the opioid epidemic while filing for bankruptcy. Plaintiffs accused the company of aggressive marketing practices that contributed to widespread opioid addiction and deaths. In … Read more

Weight-Loss Drug Makers Navigate U.S. Litigation Landscape: Lessons from the Past and Strategies for Future Defense

by

Washington, D.C. – Amid booming sales, manufacturers of GLP-1 weight-loss drugs face a new challenge: the potential for mass tort litigation similar to what has historically rocked other sectors of the American pharmaceutical industry. Industry experts suggest that drawing lessons from past litigations could be key to these manufacturers not just surviving but thriving in an increasingly litigious environment. GLP-1, or glucagon-like peptide-1 receptor agonists, have gained attention not only for their effectiveness in obesity management but also for potential side effects which could become the focal point of legal battles. Given the aggressive nature … Read more